Patent · US Active

Compounds useful for the treatment of infection with Mannheimia haemolytica or Histophilus somni

US12227485B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Thorsten Meyer · Bad Kreuznach, DE
Michael Berger · Wiesbaden, DE
Ralf Warrass · Alzey, DE
Joachim Ullrich · Stuttgart, DE

Key dates

Filing date	Jun 24, 2019
Grant date	Feb 18, 2025
Priority date	—
Expiry date	Jun 11, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D275/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention discloses compounds that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.